**Core Concept**
Clinical trials are a crucial step in the development and approval of new drugs, involving four distinct phases designed to evaluate the safety and efficacy of a medication. Each phase has a specific objective, from initial human testing to large-scale post-marketing surveillance.

**Why the Correct Answer is Right**
The phases of clinical trials are designed to systematically assess the safety and efficacy of a new drug. Phase I trials involve a small group of healthy volunteers to evaluate the drug's safety, tolerability, and pharmacokinetics. Phase II trials involve a larger group of patients with the target condition to assess the drug's efficacy and side effects. Phase III trials are randomized, controlled trials involving a large number of patients to confirm the drug's efficacy and safety in a broader population. Phase IV trials are post-marketing surveillance studies that monitor the drug's long-term safety and efficacy in a real-world setting.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify the correct sequence or details of the clinical trial phases.
**Option B:** This option is incorrect because it may be true for some aspects of clinical trials, but it is not a definitive statement about the phases.
**Option C:** This option is incorrect because it may contain some inaccuracies or misrepresentations of the clinical trial phases.

**Clinical Pearl / High-Yield Fact**
It is essential to remember that clinical trials are a critical component of the drug development process, and each phase has a distinct objective and design. Understanding the phases of clinical trials is crucial for clinicians, researchers, and patients to evaluate the safety and efficacy of new medications.

**Correct Answer:** C